세계의 성병 자가 검사 시장 : 시장 규모, 점유율 및 동향 분석(용도별, 지역별), 부문별 예측(2025-2030년)

STD Self-Testing Market Growth & Trends:

The global STD self testing market size is expected to reach USD 1.98 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.75% from 2025 to 2030. The growing demand for privacy and convenience is a key driver for the STD self-testing market, as individuals seek more discreet and accessible ways to monitor their sexual health. Many people are hesitant to visit clinics due to the stigma associated with STDs and concerns about confidentiality, especially in smaller communities or regions with limited healthcare access. Self-test kits, which offer the convenience of being taken at home, allow users to test privately without the need for clinical visits. The ease of ordering tests online and receiving quick, reliable results has significantly contributed to adopting self-testing solutions, especially among younger populations who value autonomy and confidentiality in managing their health. This trend is expected to continue driving the market as individuals seek more personalized and hassle-free healthcare options.

In addition, the rising prevalence of STDs is expected to significantly drive the STD self-testing market, as increasing infection rates underscore the need for more accessible and efficient solutions. With cases of HIV, chlamydia, syphilis, and gonorrhea rising globally, public health systems are increasingly focused on early detection and prevention strategies. Self-testing kits offer a practical solution, enabling individuals to test in the privacy of their homes and seek treatment promptly. The growing awareness of the importance of regular STD testing, combined with the convenience of at-home diagnostics, is fueling demand for these products. As STDs continue to spread, the need for faster, discreet, and user-friendly options will drive further growth in the self-testing market.

Moreover, strong support from government of several countries and strategic initiatives undratken by industry's leading players to develop kits for STI's fuel the growth of the market. For instance, the collaboration between Burnet Institute and Atomo Diagnostics on the development of a rapid active syphilis test, backed by USD 2.44 million in funding from the Australian Government, highlights a key market driver for the STD self-testing market. This lateral flow test, which uses a finger prick blood sample and a syphilis antibody assay, offers both professional and at-home self-test options, making testing more accessible, convenient, and discreet. Such innovations in rapid and user-friendly diagnostic technologies are accelerating the adoption of kits, driving growth in the broader market by meeting the demand for quicker and more reliable STD test solutions.

STD Self-Testing Market Report Highlights:

• In 2024, the CT/NG Testing segment was the largest revenue-generating sector of the STD self testing market. This is attributed to the high prevalence of these infections globally. Both Chlamydia and Gonorrhea are among the most commonly reported sexually transmitted infections, driving significant demand for rapid, accessible testing.
• The increasing adoption of self-test kits for these infections, coupled with easy-to-use and accurate diagnostic solutions, further solidifies the dominance of the CT/NG segment in the market.
• HIV Testing segment is expected to grow the fastest during the forecast period due to the rising demand for early detection and prevention. With increasing awareness about HIV and its impact, more people are seeking discreet, convenient options at home.
• The advancement in rapid HIV self-tests and government-backed initiatives are also contributing to the segment's rapid growth, offering users quick, reliable results in a private setting.
• The North American region is set to reign the global market in the year 2024 due to advanced healthcare infrastructure, strong awareness campaigns, and increasing consumer demand for convenient, at-home test solutions. The region's focus on early detection, coupled with regulatory support and innovation, further drives its market leadership.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Application
  • 1.2.2. Regional scope
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. STD Self Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising STD prevalence
    • 3.2.1.2. Advancements in rapid diagnostic technology
    • 3.2.1.3. Supportive regulatory approvals & government initiatives
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Limited awareness and accessibility
• 3.3. STD Self Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Social landscape
    • 3.3.2.5. Environmental landscape

Chapter 4. STD Self Testing Market: Application Estimates & Trend Analysis

• 4.1. Global STD Self Testing Market: Application Dashboard
• 4.2. Global STD Self Testing Market: Application Movement Analysis
• 4.3. Global STD Self Testing Market by Application , Revenue
• 4.4. CT/NG Testing
  • 4.4.1. CT/NG testing market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.5. Syphilis Testing
  • 4.5.1. Syphilis testing market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.6. HIV Testing
  • 4.6.1. HIV testing market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. STD Self Testing Market: Regional Estimates & Trend Analysis by Application and End Use

• 5.1. Regional Dashboard
• 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 5.3. North America
  • 5.3.1. U.S.
    • 5.3.1.1. Key country dynamics
    • 5.3.1.2. Regulatory framework/ reimbursement structure
    • 5.3.1.3. Competitive scenario
    • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.3.2. Canada
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Regulatory framework/ reimbursement structure
    • 5.3.2.3. Competitive scenario
    • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.3.3. Mexico
    • 5.3.3.1. Key country dynamics
    • 5.3.3.2. Regulatory framework/ reimbursement structure
    • 5.3.3.3. Competitive scenario
    • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.4. Europe
  • 5.4.1. UK
    • 5.4.1.1. Key country dynamics
    • 5.4.1.2. Regulatory framework/ reimbursement structure
    • 5.4.1.3. Competitive scenario
    • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.2. Germany
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Regulatory framework/ reimbursement structure
    • 5.4.2.3. Competitive scenario
    • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.3. France
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Regulatory framework/ reimbursement structure
    • 5.4.3.3. Competitive scenario
    • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.4. Italy
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Regulatory framework/ reimbursement structure
    • 5.4.4.3. Competitive scenario
    • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.5. Spain
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Regulatory framework/ reimbursement structure
    • 5.4.5.3. Competitive scenario
    • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.6. Norway
    • 5.4.6.1. Key country dynamics
    • 5.4.6.2. Regulatory framework/ reimbursement structure
    • 5.4.6.3. Competitive scenario
    • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.7. Sweden
    • 5.4.7.1. Key country dynamics
    • 5.4.7.2. Regulatory framework/ reimbursement structure
    • 5.4.7.3. Competitive scenario
    • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.4.8. Denmark
    • 5.4.8.1. Key country dynamics
    • 5.4.8.2. Regulatory framework/ reimbursement structure
    • 5.4.8.3. Competitive scenario
    • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.5. Asia Pacific
  • 5.5.1. Japan
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework/ reimbursement structure
    • 5.5.1.3. Competitive scenario
    • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5.2. China
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework/ reimbursement structure
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5.3. India
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework/ reimbursement structure
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5.4. Australia
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework/ reimbursement structure
    • 5.5.4.3. Competitive scenario
    • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5.5. South Korea
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Regulatory framework/ reimbursement structure
    • 5.5.5.3. Competitive scenario
    • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5.6. Thailand
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Regulatory framework/ reimbursement structure
    • 5.5.6.3. Competitive scenario
    • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.6. Latin America
  • 5.6.1. Brazil
    • 5.6.1.1. Key country dynamics
    • 5.6.1.2. Regulatory framework/ reimbursement structure
    • 5.6.1.3. Competitive scenario
    • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6.2. Argentina
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework/ reimbursement structure
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.7. MEA
  • 5.7.1. South Africa
    • 5.7.1.1. Key country dynamics
    • 5.7.1.2. Regulatory framework/ reimbursement structure
    • 5.7.1.3. Competitive scenario
    • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7.2. Saudi Arabia
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework/ reimbursement structure
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7.3. UAE
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Regulatory framework/ reimbursement structure
    • 5.7.3.3. Competitive scenario
    • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7.4. Kuwait
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Regulatory framework/ reimbursement structure
    • 5.7.4.3. Competitive scenario
    • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company market share analysis, 2024
  • 6.3.4. OraSure Technologies, Inc.
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Selfdiagnostics
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Wondfo
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. bioLytical Laboratories
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. autotest VIH
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. Abbott
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Visby Medical
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. PrivaPath Diagnostics (LetsGetChecked)
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. NOWDiagnostics
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives